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Association between depressive-
symptom trajectories and cognitive 
function in the late middle-aged 
and older population: results of 
the Korean Longitudinal study of 
Ageing
Dong-Woo Choi1,2, Kyu-Tae Han3, Jooeun Jeon1, Sung-In Jang2,4, Seung Ju Kim  5 &  
eun-Cheol park  2,4
this study investigated the association between depressive symptoms and cognitive function according 
to four different trajectories of depressive symptoms in the late middle-aged and older South Korean 
population. panel data from the Korean Longitudinal study of Ageing were analyzed. We used latent 
class trajectory models to identify four trajectories of depressive symptoms. We performed linear 
mixed-effects regression analysis to assess associations between depressive-symptom trajectories and 
MMSE scores. Of 4,374 participants, 18.4%, 4.9%, 55.2%, and 21.5% were classified as having a low, 
increasing, moderate declining, and high depressive-symptom trajectory, respectively. Individuals 
with an increasing trajectory (β = −0.729, P ≤ 0.001), moderate trajectory (β = −0.278, P = 0.003), 
and high trajectory (β = −1.605, P ≤ 0.001) had lower MMSE scores compared with those in the low 
trajectory group. these relationships were particularly strong among women; individuals who were 
physically inactive; those who were separated, divorced, or single; and those with hypertension or 
cerebrovascular disease. each trajectory group for depressive symptoms was associated with cognitive 
decline. Moreover, female, physically inactive, and single individuals, as well as those with hypertension 
and cerebrovascular disease should be particularly mindful of their mental and physical health to 
prevent cognitive decline.
In South Korea, dementia has become a health priority because of the rapidly aging population. Indeed, South 
Korea already became aged society in 2017 and it is predicted that 38.2% of the Korean population is likely to 
be aged 65 years or older by 2050, which is much higher than that forecasted for other developed countries1. 
Cognitive function decline is the most common health problem among the elderly. Moreover, early-onset demen-
tia is not uncommon among 45- to 65-year-old individuals and reportedly accounts for approximately one-third 
of all patients with dementia in developed countries2–4. Age-related cognitive decline is highly variable with little 
or no decline in many individuals but slight to precipitous decline in others5–7. It is associated with several factors, 
such as mental disease, chronic disease, and environmental factors8,9. Among these, depression is a well-known 
risk factor and a major worldwide public health concern10.
Depressive symptoms are affected by an individual’s subjective mood at the time of assessment and can vary 
throughout one’s life11,12. Moreover, patterns of symptoms vary among individuals, with some experiencing 
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chronic depression, others experiencing sudden increases in depressive symptoms in reaction to life events, and 
others experiencing periods of relative remission from depression that may be punctuated by intermittent relapses 
of symptoms. These different patterns of change in depressive symptoms might be affected by several risk factors, 
including an individual’s environment and health behaviors, as well as biological, genetic, and social factors13–15.
Although some previous studies have noted the importance of considering different patterns of depressive 
symptoms, most studies investigating the relationship between depression and cognitive function have assessed 
depressive symptoms cross-sectionally or as a repeated measure without considering the individual character-
istics of changes in depressive symptoms16. Moreover, in the general population, individuals experience several 
changes in the course of their depressive symptoms, each of which might be related to different risk factors or 
outcomes.
Approaches that consider the different patterns in depressive symptoms could aid health policy makers and 
health professionals to develop optimized health policies for dementia by considering individual characteristics 
for more efficient use of limited health resources. Thus, this study investigated the association between depres-
sive symptoms and cognitive function according to four different trajectories of depressive symptoms in the late 
middle-aged and older South Korean population.
Methods
study population. We analyzed panel data from the Korean Longitudinal Study of Ageing (KLoSA) waves 
2 (2008) to 6 (2016). The KLoSA data included those of participants aged 45 years or older living in households 
selected by multistage stratified probability sampling to be representative of the nation. Follow-up examinations 
conducted via home interviews took place every 2 years.
In the current study, we included all participants enrolled from 2008 to 2016. However, we excluded individ-
uals with suspected dementia (represented by a Mini-Mental State Examination (MMSE) score lower than 17 
in 200817). We also excluded those who did not provide responses for relevant covariates when completing the 
questionnaires of the KLoSA. Accordingly, 4,374 participants were included in this study.
Variables. The primary outcome was the MMSE score. The MMSE is a global measurement of cognition, 
with domains for orientation, concentration, language, praxis, and immediate and delayed memory. The Korean 
version of this test was administered according to standardized procedures, with a total score ranging from 0 to 
30 where lower scores represent poor cognitive functioning18.
We focused primarily on depressive symptoms by using the 10-item version of the Center for Epidemiology 
Depression Scale (CES-D10). The CES-D10 has excellent properties for use as a screening tool to identify major 
depressive symptoms in older adults19.
We assessed several covariates, including sex, age, educational level (“elementary school or under,” “middle 
school,” “high school,” or “university or above”), household assets quartile (1st, 2nd, 3rd, or 4th quartile), employ-
ment status (“employed” or “unemployed”), marital status (“married” or “separated, divorced, or single”), body 
mass index (BMI, “pre-obesity or obesity,” “overweight,” or “normal or underweight”), physical activity (“at least 
once a week” or “none”), alcohol consumption (“drinker,” “ex-drinker,” or “non-drinker”), smoking behavior 
(“current smoker,” “ex-smoker,” or “non-smoker”), and the presence of hypertension or cerebrovascular disease 
(previously diagnosed by a doctor).
statistical analysis. We used latent class trajectory models to identify trajectories of depressive symptoms 
according to the CES-D10 over the follow-up period. This is a specialized form of finite mixture modelling, which 
describes the course of depressive symptomatology through a regression function using continuous latent growth 
factors (intercept, slope, quadratic slope, and cubic slope). The intercept represents the level of depressive symp-
toms at baseline. The change in depressive symptoms over time is accounted for by one or more growth factors 
such as a linear, quadratic, or cubic slope.
We calculated the posterior probabilities for each trajectory taking into account the participant’s age (at base-
line of depressive symptoms), educational level, BMI, smoking status, alcohol status, employment status, edu-
cational level, and household assets. Subsequently, we assigned participants post hoc to the trajectory with the 
highest probability. We estimated the best-fitting trajectory based on a minimum Bayesian information criterion. 
To facilitate interpretability, we labeled trajectories based on their modeled plot patterns as “low CES-D trajec-
tory,” “increasing CES-D trajectory,” “moderate declining CES-D trajectory,” and “high CES-D trajectory.”
We conducted analysis of variance and chi-square tests for the descriptive statistics of the trajec-
tories. Thereafter, we performed linear mixed-effects regression to assess the relationship between the 
depressive-symptom trajectory groups and the MMSE score after adjusting for covariates, including sex, age, 
education level, household assets, employment status, marital status, BMI, physical activity, alcohol con-
sumption, smoking, hypertension, and cerebrovascular disease. The linear mixed-effects regression examined 
within-individual changes and between-individual differences in change over time. Thereafter, we conducted 
subgroup analyses for sex, marital status, physical activity, hypertension, and cerebrovascular disease using the 
linear mixed-effects model.
Finally, we stratified the follow-up period into 2008 to 2010, 2010 to 2012, 2012 to 2014, and 2012 to 2016 
to explore the possibility of reverse causality. All statistical analyses were conducted with SAS version 9.4 (SAS 
institute, Inc., Cary, NC, USA). Statistical significance was defined as P < 0.05.
ethics approval and consent to participate. The Korean Longitudinal Study of Ageing data are openly 
published. Thus, ethical approval was not required for this study. This study did not require informed consent 
from the participants, as their information was fully anonymized and unidentified prior to analysis.
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Results
Figure 1 presents the four trajectories of depressive symptoms between 2008 and 2016 in the 4,374 participants. 
Participants were classified as maintaining a low CES-D10 score throughout the follow-up period (n = 804, 
18.4%), beginning with a low CES-D10 score that rapidly increased (n = 215, 4.9%), having a moderate declining 
CES-D10 score (n = 2,413, 55.2%), or maintaining a high CES-D10 score (n = 942, 21.5%).
Table 1 shows the general characteristics of the baseline population according to their identified trajectories. 
In each of the four trajectories, 49%, 47%, 43%, and 45% of the respective participants were male. The greatest 
proportion of married individuals were in the low CES-D trajectory group (n = 714, 88.8%), followed by the 
increasing CES-D trajectory group (n = 186, 86.5%), moderate declining CES-D trajectory group (n = 2,025, 
83.9%), and high CES-D trajectory group (n = 712, 75.6%). The mean CES-D10 scores for each trajectory were 
0.4 ± 0.9 (low trajectory), 0.8 ± 1.7 (increasing CES-D trajectory), 3.1 ± 2.3 (moderate declining CES-D trajec-
tory), and 6.3 ± 1.9 (high CES-D trajectory). The overall mean CES-D10 score was 2.9 ± 2.7. The mean MMSE 
scores were 27.0 ± 2.8, 25.6 ± 4.0, 26.3 ± 3.2, and 24.5 ± 4.2 for the low, increasing, moderate declining, and high 
trajectories, respectively, and the overall mean MMSE score was 26.1 ± 4.1.
Table 2 presents the results of the linear mixed-effects regression to investigate the association between tra-
jectory groups of depressive symptoms and MMSE scores. We observed that there was a statistically significant 
inverse relationship between the CES-D10 scores and MMSE scores (β = −0.124, P ≤ 0.001). Among the CES-D 
trajectory groups, the increasing CES-D trajectory (β = −0.729, P ≤ 0.001), moderate declining CES-D trajectory 
(β = −0.278, P = 0.003), and high CES-D trajectory (β = −1.605, P ≤ 0.001) groups were associated with a lower 
MMSE score than was the low CES-D trajectory group. We did not observe any significant differences between the 
sexes. However, separated, divorced, or single individuals had lower MMSE scores than did married participants 
(β = −0.278, P = 0.001). Meanwhile, participants who engaged in physical activity had higher MMSE scores than 
did those who did not (β = 0.513, P ≤ 0.001). Finally, participants with hypertension (β = −0.267, P ≤ 0.001) or 
cerebrovascular disease (β = −1.339, P ≤ 0.001) had lower MMSE scores than did those without these conditions.
Figure 2 presents the results of the subgroup analyses in which we assessed the relationship between the 
CES-D10 score trajectories and MMSE scores according to sex, marital status, and physical activity. We observed 
that women in the increasing (β = −1.114, P ≤ 0.001), moderate declining (β = −0.347, P = 0.011), and high 
(β = −1.810 P ≤ 0.001) CES-D trajectory groups had lower MMSE scores than did those in the low CES-D tra-
jectory group. However, among men, only those in the high CES-D trajectory group had lower MMSE scores 
than those in the low CES-D trajectory group (β = −1.337, P ≤ 0.001). Among separated, divorced, or single 
participants, those with increasing (β = −1.685, P = 0.003), moderate declining (β = −0.787, P = 0.019), and high 
(β = −2.044, P ≤ 0.001) CES-D trajectories had lower MMSE scores than did those with a low CES-D trajectory. 
In participants who did not engage in physical activity, those with increasing (β = −0.810, P = 0.004), moderate 
declining (β = −0.400, P = 0.011), and high (β = −1.897, P ≤ 0.001) CES-D trajectories had lower MMSE scores 
than did those with a low CES-D trajectory (Table S1 in Supplementary).
Figure 3 presents the results of the subgroup analysis for the association between the trajectory groups of 
depressive symptoms and MMSE scores in a mixed-effects model according to hypertension and cerebrovas-
cular disease. Among participants with hypertension, those with increasing (β = −0.810, P = 0.004), moderate 
declining (β = −0.400, P = 0.011), and high (β = −1.897, P ≤ 0.001) CES-D trajectories had lower MMSE scores 
than did those with a low CES-D trajectory. However, among the participants with cerebrovascular disease, only 
those in the high CES-D trajectory group had a lower MMSE score than those in the low CES-D trajectory group 
(β = −2.501, P = 0.027).
Figure S1 in Supplementary shows the association between the depressive-symptom trajectory groups and the 
MMSE scores in the follow-up groups of 2008–2010, 2010–2012, 2012–2014, and 2014–2016. Compared with the 
low trajectory group, the increasing and high trajectory groups had lower MMSE scores in 2008–2010 (increas-
ing CES-D: β = −0.650, P ≤ 0.001; high CES-D: β = −1.222, P ≤ 0.001) and 2010–2012 (increasing CES-D: 
β = −0.923, P ≤ 0.001; high CES-D: β = −1.284, P ≤ 0.001). During 2012–2014, the increasing (β = −0.891, 
P ≤ 0.001), moderate declining (β = −0.247, P = 0.042), and high (β = −1.585, P ≤ 0.001) trajectory groups 
had lower MMSE scores than did the low trajectory group. Between 2014–2016, only the moderate declining 
(β = −0.481, P ≤ 0.001) and high (β = −1.906, P ≤ 0.001) CES-D trajectory groups had lower MMSE scores than 
did the low trajectory group.
Figure 1. Trajectories for the CES-D10 scores between 2008 and 2016 in each group.
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Discussion
In this study, we identified four groups according to their trajectories of changes in depressive symptoms, which 
we classified as low, increasing, moderate declining, and high depressive-symptom trajectories. We observed 
that cognitive-function decrease was higher in the increasing, moderate declining, and high trajectory groups 
than that in the low trajectory group across the 8- year study period in this late middle-aged and older popu-





trajectory (N = 804)
Moderated declining CES-D10 
trajectory (N = 2,413)
Increasing CES-D10 
trajectory (N = 215)
High CES-D10 
trajectory (N = 942) P-value
CES-D10 score† 3.0 ± 2.7 1.0 ± 1.6 3.3 ± 2.5 0.5 ± 1.0 5.5 ± 2.4
MMSE score† 26.0 ± 3.8 27.7 ± 2.6 27.2 ± 2.7 27.0 ± 3.0 25.6 ± 3.2
Sex <0.001
Men 1,968 48.8 43.3 47.0 45.5
Women 2,406 51.2 56.7 53.0 54.5
Age (years) <0.001
45–54 1,362 35.1 31.2 33.5 27.0
55–64 1,540 37.7 35.0 37.2 33.2
65–74 1,180 22.3 27.7 24.7 29.7
≥75 292 5.0 6.1 4.7 10.1
Educational level <0.001
Elementary school or under 1,703 35.3 39.3 38.1 41.2
Middle school 819 19.0 18.7 16.3 19.0
High school 1,444 34.6 33.4 37.2 29.7
University or above 408 11.1 8.5 8.4 10.1
Household assets quartile 0.690
1st quartile 949 20.4 19.9 20.9 27.7
2nd quartile 1,051 25.1 24.8 26.5 20.6
3rd quartile 1,193 26.7 28.8 25.6 24.3
4th quartile 1,181 27.7 26.6 27.0 27.4
Employment status <0.001
Employed 2,179 52.6 50.1 52.1 46.2
Unemployed 2,195 47.4 49.9 47.9 53.8
Marital status 0.064
Married 3,760 89.9 87.2 89.3 78.8
Separated, divorced, or single 614 10.1 12.8 10.7 21.2
BMI 0.335
Pre-obesity or obesity 1,000 21.0 23.0 28.4 22.9
Overweight 1,427 32.0 33.4 33.5 31.0
Normal or underweight 1,947 47.0 43.6 38.1 46.1
Physical activity 0.001
Yes 1,786 44.3 42.4 37.2 34.7
No 2,588 55.7 57.6 62.8 65.3
Alcohol behavior 0.131
Drinker 1,802 42.3 41.3 36.7 41.1
Ex-drinker 340 7.6 8.1 5.1 7.7
Non-drinker 2,232 50.1 50.6 58.1 51.2
Smoking behavior 0.259
Current smoker 812 19.9 17.6 16.7 20.3
Ex-smoker 532 11.9 12.6 11.2 11.4
Non-smoker 3,030 68.2 69.7 72.1 68.4
Hypertension 0.558
Present 1,242 25.9 28.6 24.2 31.0
Absent 3,132 74.1 71.4 75.8 69.0
Cerebrovascular disease <0.001
Present 93 0.5 2.3 0.9 3.4
Absent 4,281 99.5 97.7 99.1 96.6
Total 4,374 18.4 55.2 4.9 21.5
Table 1. Baseline characteristics of study population. †Mean and standard deviation (SD) of the continuous 
independent variables in this study. ‡Categorical variables are presented as frequencies and percentages.
5Scientific RepoRts |          (2019) 9:7807  | https://doi.org/10.1038/s41598-019-44158-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
divorced, or single individuals; and those with hypertension or cerebrovascular disease, particularly if they had 
rapidly-increasing or chronically-high depressive symptoms. Moreover, these relationships were maintained 
across all follow-up periods (i.e., 2008–2010, 2010–2012, 2012–2014, and 2014–2016).
We suggest that each trajectory of depressive symptoms during the 8-year period could be useful to predict 
differential risk factors and to more accurately distinguish people at risk of cognitive decline. We observed that 
not only people in the high trajectory group but also those with a sharp increase in depressive symptoms had a 
high risk of cognitive-function decline. Moreover, participants in the increasing, moderate declining, and high 
depressive symptom trajectories tended to be older, of female sex, poorly educated, living alone, and physically 
inactive, as well as more likely to have hypertension or cerebrovascular disease compared with those in the low 
depressive-symptom trajectory. Previous studies have found that poor physical health status, involving, among 
others, chronic diseases and functional limitations, was related to an increase in the risk of depressive symp-
toms20–22. Similar characteristics of participants classified to each trajectory have also been reported by previous 
studies16,20,23. The MMSE scores in the increasing, moderate declining, and high depressive-symptom trajectory 
groups were lower by approximately 0.3 to 1.6 points than in the low depressive-symptom trajectory group. This 
further supports the assertion that the moderate declining, high and increasing trajectory groups were also at risk 
of decreased cognitive function.
Previous research has also suggested that participants with steadily-increasing depressive symptoms have a 
high risk of dementia16. Although the underlying mechanisms remain to be identified, it is known that elderly 
people with depression have more cerebral white matter and other subcortical abnormalities compared with 
healthy elderly people24,25. Neurodegenerative diseases, such as Alzheimer’s disease and vascular dementia, may 





Low CES-D10 trajectory Ref.
Moderate declining 
CES-D10 trajectory −0.278 0.094 0.003
Increasing CES-D10 
trajectory −0.729 0.173 <0.001
High CES-D10 trajectory −1.605 0.119 <0.001
Table 2. Results of the association between the trajectory groups of depressive symptoms and MMSE scores in 
a mixed-effects regression analysis. †Analysis was adjusted for the following covariates: sex, age, education level, 
household assets, employment status, marital status, BMI, physical activity, alcohol consumption, smoking, 
hypertension, and cerebrovascular disease.
Figure 2. Results of the subgroup analysis for the association between the trajectory groups of depressive 
symptoms and MMSE scores in a mixed-effects model according to sex, marital status, and physical activity. 
†Analysis was adjusted for the following covariates: sex, age, education level, household assets, employment 
status, marital status, BMI, physical activity, alcohol consumption, smoking, hypertension, and cerebrovascular 
disease. ‡The color bars indicate statistically significant results (P < 0.05).
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these conditions may initially present with depressive symptoms26,27, such that depression may represent the early 
stages of a neurodegenerative disease. Therefore, people with high and rapidly-increasing depressive symptoms 
may likely be at risk of developing dementia.
To investigate the potential presence of reverse causality, we stratified the follow-up period into 2008–2010, 
2010–2012, 2012–2014, and 2014–2016. In this analysis, we observed an identical trend of a significantly negative 
association between depressive symptoms and MMSE scores in all trajectory groups, except for the moderate 
declining trajectory group. In particular, there was a stronger relationship between depressive symptoms and 
cognitive-function decline in the participants in the high trajectory groups, who had chronic depressive symp-
toms, compared with those in the other trajectory groups, which was consistent across the investigated time 
periods. These results suggest that people with chronic depression are likely to be at higher risk of dementia and 
should be especially targeted for prevention and management.
In the subgroup analysis of sex, women had lower MMSE scores in the increasing, moderate declining, 
and high depressive-symptom trajectory groups compared with the low trajectory group. In contrast, among 
men, only those in the high depressive-symptom trajectory group had decreased MMSE scores compared with 
those in the low trajectory group. Moreover, the coefficients for all trajectories, but especially for the increasing 
trajectory, were larger in women than in men. This indicates that depressive symptoms had a greater effect on 
cognitive-function decline in women than in men.
It is possible that high levels of cortisol may be associated with depression and may also lead to neuronal 
death and cognitive decline. High cortisol levels or other manifestations of hypothalamic-pituitary-adrenal axis 
dysregulation are more common among women and might be associated with depressive symptoms and poor 
cognitive function. Such dysregulation may account for the more severe cognitive decreases seen in women. It 
is also possible that depressive symptoms and cognitive decline are both attributable to an underlying genetic 
predisposition27–29.
We also observed that people who were separated, divorced, or single had greater MMSE score declines than 
did those who were married in all depressive-symptom trajectories, but especially the increasing and high tra-
jectory groups. This is consistent with the findings of a previous study in which it was observed that married 
people had a low risk of MMSE decline30. Strong social networks may protect against cognitive decline. Therefore, 
being married may represent being part of a family social network, which can help reduce declining cognitive 
function31.
Moreover, the physical-inactive group showed a strong association with decline in cognitive function in all 
trajectories of depressive symptoms compared to the physical-active group. Physical activity has been reported 
to both postpone cognitive-function decline and to prevent depression32,33. Although the mechanisms of these 
benefits are not clear, some possibilities include an alteration in cerebral vascular functioning and brain perfusion 
or environment enrichment associated with greater physical activity34,35. Thus, we suggest that people who are 
physically inactive should be encouraged to increase the time they spend engaging in physical activities, as this 
would benefit their mental health, as well as help avoid neurodegenerative disease.
Both hypertension and cerebrovascular disease have been related to worsened cognitive performance36,37. 
In our study, participants with hypertension or cerebrovascular disease in the high depressive-symptom trajec-
tory group had greater declines in cognitive function than did those without these conditions. Although par-
ticipants with hypertension in all trajectory groups showed a strong relationship between depressive symptoms 
Figure 3. Results of the subgroup analysis for the association between the trajectory groups of depressive 
symptoms and MMSE scores in a mixed-effects model according to hypertension and cerebrovascular disease. 
†Analysis was adjusted for the following covariates: sex, age, education level, household assets, employment 
status, marital status, BMI, physical activity, alcohol consumption, smoking, hypertension, and cerebrovascular 
disease. ‡The color bars indicate statistically significant results (P < 0.05).
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and cognitive decline, for participants with cerebrovascular disease, this strong association was only seen among 
those in the high trajectory group. Nonetheless, these results suggest that patients with these conditions should 
be supported to effectively manage their physical and mental health to postpone the onset of cognitive decline.
This study is subject to several limitations. First, despite the use of the CES-D10 and MMSE, the participant 
scores may have been subjective or erroneous. Second, although our trajectory model was fitted based on assigned 
trajectories, we did not fully consider the uncertainty of class membership of each participant, which signifies that 
the variance estimates from this model are likely to be underestimated. Third, health behaviors such as alcohol 
consumption, smoking, and physical activity were not assessed with specific scales. Fourth, we could not fully 
assess sex differences for patterns of depressive-symptom trajectories and cognitive function. Further studies are 
needed to evaluate pertinent sex differences. Fifth, we cannot exclude the possibility that the associations found 
in our analysis may in fact be due to cohort effects due to the unstructured, multicohort, longitudinal design 
of the study and the broad age range of the participants38. This study included participants 60 years or older at 
baseline, who experienced the Korean War in 1950–1953, as well as “baby boomer” participants in their 40’s and 
50’s at baseline, whose life experiences were markedly different. The different life experiences of these cohorts 
may have had unknown effects on depressive symptoms and cognitive function39. Therefore, the results should be 
interpreted carefully, and further research needs to consider this effect. Finally, we may not have fully controlled 
for all potential risk or confounding factors in this study. However, despite these limitations, our study has several 
strengths. First, the study had a relatively long follow up and used a representative elderly sample. Second, we 
investigated both the long- and short-term effects of depressive symptoms on cognitive-function decline using 
different courses of depressive symptoms with respect to increased risk of dementia. Finally, we stratified the 
follow-up period from 2008 to 2016 for each 2 years to explore the possibility of reverse causal relations.
In conclusion, participants in all depressive-symptom trajectory groups, classified by repeated measurements, 
showed decreased MMSE scores over the follow-up period. However, women, the physically inactive, and those 
with hypertension or cerebrovascular disease had worse cognitive function, suggesting a need to manage the 
mental health of such individuals through psychiatric consultation or by visiting clinics for the prevention of 
dementia, particularly if they have rapidly-increasing or chronically-high depressive symptoms. Public health 
professionals and policymakers should consider our findings when developing optimal health policies for the 
prevention of dementia.
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